Allergologie select, Volume 6 (2022) - 1st Issue (148 - 166)

Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP)
Ludger Klimek1,2, Jan Hagemann2, Hans-Jürgen Welkoborsky3, Mandy Cuevas4, Ingrid Casper1, Ulrike Förster-Ruhrmann5, Felix Klimek1, Constantin A. Hintschich6, Tilman Huppertz2, Christoph Bergmann7, Peter-Valentin Tomazic8, Sven Becker9
1 Center for Rhinology and Allergology, Wiesbaden, 2 Clinic and Polyclinic for Otolaryngology, University Medical Center Mainz, Mainz, 3 Clinic for Ear, Nose and Throat Medicine, Head and Neck Surgery, Nordstadt Clinic of the KRH, Hannover, 4 Clinic and Polyclinic for Otolaryngology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, 5 HNO-University Clinic Charité, Berlin, 6 Clinic and Polyclinic for Ear, Nose and Throat Medicine, University Hospital Regensburg, Regensburg, 7 HNO RKM 7  4  0  Interdisciplinary Specialist Clinic, Düsseldorf, Germany, 8 HNO-University Clinic Graz, Medical University Graz, Austria, and 9 HNO-University Clinic Tübingen, Germany

   

 

DOI 10.5414/ALX02296E

Abstract

Background: The epithelial immune regulation is an essential and protective feature of the barrier function of the mucous membranes of the airways. Damage to the epithelial barrier can result in chronic inflammatory diseases, such as chronic rhinosinusitis (CRS) or bronchial asthma. Thymic stromal lymphopoietin (TSLP) is a central regulator in the epithelial barrier function and is associated with type 2 (T2) and non-T2 inflammation. Materials and methods: The immunology of chronic rhinosinusitis with polyposis nasi (CRSwNP) was analyzed in a literature search, and the existing evidence was determined through searches in Medline, Pubmed as well as the national and international study and guideline registers and the Cochrane Library. Human studies or studies on human cells that were published between 2010 and 2020 and in which the immune mechanisms of TSLP in T2 and non-T2 inflammation were examined were considered. Results: TSLP is an epithelial cytokine (alarmin) and a central regulator of the immune reaction, especially in the case of chronic airway inflammation. Induction of TSLP is implicated in the pathogenesis of many diseases like CRS and triggers a cascade of subsequent inflammatory reactions. Conclusion: Treatment with TSLP-blocking monoclonal antibodies could therefore open up interesting therapeutic options. The long-term safety and effectiveness of TSLP blockade has yet to be investigated.

Author Details

Authors

Departments

  • 1 Center for Rhinology and Allergology, Wiesbaden,
  • 2 Clinic and Polyclinic for Otolaryngology, University Medical Center Mainz, Mainz,
  • 3 Clinic for Ear, Nose and Throat Medicine, Head and Neck Surgery, Nordstadt Clinic of the KRH, Hannover,
  • 4 Clinic and Polyclinic for Otolaryngology, University Hospital Carl Gustav Carus, TU Dresden, Dresden,
  • 5 HNO-University Clinic Charité, Berlin,
  • 6 Clinic and Polyclinic for Ear, Nose and Throat Medicine, University Hospital Regensburg, Regensburg,
  • 7 HNO RKM
  • 7 
  • 4 
  • 0  Interdisciplinary Specialist Clinic, Düsseldorf, Germany,
  • 8 HNO-University Clinic Graz, Medical University Graz, Austria, and
  • 9 HNO-University Clinic Tübingen, Germany

Address

Prof. Dr. med. L. Klimek, Zentrum für Rhinologie und Allergologie Wiesbaden, An den Quellen 10, 65183 Wiesbaden, Germany
Email: [email protected]

Citation

Ludger Klimek, Jan Hagemann, Hans-Jürgen Welkoborsky, Mandy Cuevas, Ingrid Casper, Ulrike Förster-Ruhrmann, Felix Klimek, Constantin A. Hintschich, Tilman Huppertz, Christoph Bergmann, Peter-Valentin Tomazic, and Sven Becker.Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP). 2022; 6: 148-166. doi: 10.5414/ALX02296E.

###article_not_exists_msg###

Warenkorb Übersicht

Warenkorb Übersicht
Typ Anz Rabatt MwSt Preis
Der Warenkorb ist leer
Ihr Warenkorb